Oncocyte Corp Quarterly Operating Margin in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Oncocyte Corp quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q2 2024.
  • Oncocyte Corp Operating Margin for the quarter ending June 30, 2024 was -3.58K %, a 149% decline year-over-year.
  • Oncocyte Corp annual Operating Margin for 2023 was -1.67K %, a 11% increase from 2022.
  • Oncocyte Corp annual Operating Margin for 2022 was -1.88K %, a 23.1% increase from 2021.
  • Oncocyte Corp annual Operating Margin for 2021 was -2.44K %, a 0.04% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -3.58K -2.14K -149% Apr 1, 2024 Jun 30, 2024
Q1 2024 -2.91K -1.87K -179% Jan 1, 2024 Mar 31, 2024
Q4 2023 -1.67K +206 +11% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.41K -425 -43.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.43K -396 -38.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.04K -100 -10.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.88K -918 -95.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -984 -18.3 -1.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.04K -150 -16.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -943 +461 +32.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -960 +1.48K +60.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -965 Jul 1, 2021 Sep 30, 2021
Q2 2021 -889 Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.4K Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.44K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.